Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

THEMIS MEDICARE LTD.

NSE : THEMISMEDBSE : 530199ISIN CODE : INE083B01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE216.305.45 (+2.58 %)
PREV CLOSE () 210.85
OPEN PRICE () 208.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3972
TODAY'S LOW / HIGH ()208.20 218.30
52 WK LOW / HIGH ()131.34 266
NSE216.406.25 (+2.97 %)
PREV CLOSE() 210.15
OPEN PRICE () 211.30
BID PRICE (QTY) 216.40 (1434)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 44101
TODAY'S LOW / HIGH() 208.65 219.00
52 WK LOW / HIGH ()132.6 263.85
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1969

Management Info :

Dinesh S Patel - Chairman Sachin D Patel - Managing Director

Registered Office :

Address : Plot No 69 A,G I D C Industrial Estate, ,
Vapi,
Gujarat-396195

Phone : 0260-2431447/ 2430219

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
16Apr Themis Medicare informs about complian
Themis Medicare has informed that it enclosed the Compliance Certificate..
08Apr Themis Medicare informs about certific
Themis Medicare has informed that it enclosed a Certificate under Regula..
12Mar Themis Medicare informs about newspape
In terms of Regulation 47 of the SEBI Listing Regulations, Themis Medica..
10Nov Themis Medicare launches novel Opioid
Themis Medicare has launched a novel Opioid Injectable Analgesic Remifen..
06Nov Themis Medicare informs about newspape
In terms of Regulations 47 of the SEBI Listing Regulations, Themis Medic..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit20.01432.94
Gross Profit 28.52 589.08
Operating Profit 86.33789.67
Net Sales 825.133543.23
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Divi's Lab (BSE)
 4025.35 (4.81%)
M.Cap ( in Cr)
106860.39
Sanofi India (BSE)
 8278.10 (1.76%)
M.Cap ( in Cr)
19064.98
Abbott India (BSE)
 25864.85 (0.54%)
M.Cap ( in Cr)
54961.00
Astrazeneca Pharma I (BSE)
 5415.40 (2.18%)
M.Cap ( in Cr)
13538.50
Glaxosmithkline Phar (BSE)
 2132.75 (3.26%)
M.Cap ( in Cr)
36130.07
Shareholding Pattern
PROMOTERS 67.15%
NON-INSTITUTION 32.81%
FI/BANKS/INSURANCE 0.01%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
Motilal Oswal S&P B...0.07
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX73730.16-609.28 (-0.82%)
NIFTY22419.95-150.40 (-0.67%)
Dow Jones 38085.80-375.12 (-0.98%)
Nasdaq 15611.76-100.99 (-0.64%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI